Singapore Clinical Research Institute (SCRI) is an Academic Research Organisation dedicated to enhance the standards of human clinical research. Its vision is to develop SCRI and Singapore Scientists as an ASEAN hub for clinical research excellence. SCRI is a wholly-owned subsidiary of Ministry of Health Holdings, Singapore. SCRI strives to improve patient care through the design and conduct of high-quality, cutting-edge clinical studies. SCRI supports academic, public-sector and industry-sponsored studies ranging from proof-of-concept to late-phase clinical trials and epidemiological studies. In its efforts to enhance clinical research capacity building in Singapore and the region, SCRI also spearheads the planning and delivery of educational and training programs on various aspects of clinical research. In driving towards its vision, SCRI collaborates with clinicians to enhance Singapore’s clinical research capabilities and strengthen its expertise in executing multi-site, multi-national research and the development of regional clinical research networks.